Combined Prophylaxis with Uterotonics and Tranexamic Acid for  Intrapartum Postpartum Hemorrhage (PPH): Hemostatic,  Pharmacologic, Cardiac, and Anesthetic Considerations by Risk  Category — A Decade Review of Randomized Controlled Trials

Dr. Muniba Ali,Dr. Aisha Ali,Dr. Nimra Samad,Dr. Syed Shayan Ahmed,Dr. Syed Hasnain Mujtaba,Dr. Pavan Kumar,Dr. Amber Shams

Combined Prophylaxis with Uterotonics and Tranexamic Acid for Intrapartum Postpartum Hemorrhage (PPH): Hemostatic, Pharmacologic, Cardiac, and Anesthetic Considerations by Risk Category — A Decade Review of Randomized Controlled Trials

Authors

Dr. Muniba Ali,Dr. Aisha Ali,Dr. Nimra Samad,Dr. Syed Shayan Ahmed,Dr. Syed Hasnain Mujtaba,Dr. Pavan Kumar,Dr. Amber Shams

Keywords:

Abstract

Postpartum hemorrhage (PPH) remains the leading direct cause of maternal mortality worldwide, with uterine atony accounting for nearly 70% of cases. Conventionalprophylaxis relies on uterotonics

References

◆ Ononge S, Mirembe F, Wandabwa J. TXA in anemic parturients: RCT. Int J Gynaecol Obstet. 2015;130(1):13-17. PMID: 25744280.

Downloads

Published

2025-12-03

How to Cite

Dr. Muniba Ali,Dr. Aisha Ali,Dr. Nimra Samad,Dr. Syed Shayan Ahmed,Dr. Syed Hasnain Mujtaba,Dr. Pavan Kumar,Dr. Amber Shams. (2025). Combined Prophylaxis with Uterotonics and Tranexamic Acid for Intrapartum Postpartum Hemorrhage (PPH): Hemostatic, Pharmacologic, Cardiac, and Anesthetic Considerations by Risk Category — A Decade Review of Randomized Controlled Trials. International Journal of Pharmacy Research & Technology (IJPRT), 15(2), 3570–3583. Retrieved from https://www.ijprt.org/index.php/pub/article/view/1263